Medtronic (MDT) Change in Receivables (2014 - 2026)

Medtronic has reported Change in Receivables for 13 years, with the latest figure at $287.0 million in Q2 2026.

• Quarterly Change in Receivables rose 15.26% year-over-year to $287.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $200.0 million (down 53.81% YoY) and the FY2026 annual result came in at $200.0 million, down 53.81% from the prior year.
• Change in Receivables improved to $287.0 million in Q2 2026 per MDT's latest filing, from -$13.0 million in the prior quarter.
• Over five years, Change in Receivables peaked at $435.0 million in Q4 2022 and troughed at -$288.0 million in Q3 2025.
• A 5-year average of $105.9 million and a median of $115.0 million in 2023 frame the typical range for Change in Receivables.
• The sharpest annual moves came in 2022 and 2026: Change in Receivables soared 232.06% in 2022, then plunged 533.33% in 2026.
• Over 5 years, Change in Receivables stood at $435.0 million in 2022, then slumped by 35.4% to $281.0 million in 2023, then gained by 3.56% to $291.0 million in 2024, then decreased by 26.46% to $214.0 million in 2025, then jumped by 34.11% to $287.0 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $287.0 million, -$13.0 million, and $214.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.